Therapeutic Asset Ratings
308 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
imm60
Melanoma
iOx Therapeutics
P1/2
CC
(41)
Immunoglobulin G1 [de-448-lysine], anti-(human cytotoxic T-lymphocyte-associated protein 4) (human monoclonal BA3071 ?1-chain), disulfide with human monoclonal BA3071 ?-chain, dimer
Melanoma
BioAtla, Inc.
P1/2
CC
(41)
Immunoglobulin G1 [de-C-terminal-lysine], anti-(human CC chemokine receptor CCR8) (human-Mus musculus monoclonal BMS-986340 ?1-chain), disulfide with human-Mus musculus monoclonal BMS-986340 ?-chain, dimer
Melanoma
Bristol-Myers Squibb
P1/2
CC
(41)
Inbrx-106
Melanoma
Inhibrx Biosciences, Inc
P1/2
CC
(41)
Interleukin 18 (recombinant human mutein clone ST-067)
Melanoma
Simcha IL-18, Inc.
P1/2
CC
(41)
ipn01194
Melanoma
Ipsen
P1/2
CC
(41)
jk08
Melanoma
Salubris Biotherapeutics Inc
P1/2
CC
(41)
kd6001
Melanoma
Shanghai Kanda Biotechnology Co., Ltd.
P1/2
CC
(41)
Ksq-001Ex
Melanoma
M.D. Anderson Cancer Center
P1/2
CC
(41)
n17350
Melanoma
Onchilles Pharma Inc
P1/2
CC
(41)
neo212
Melanoma
Neonc Technologies, Inc.
P1/2
CC
(41)
ng2 and dll3 car-t cells
Melanoma
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(41)
ngm707
Melanoma
NGM Biopharmaceuticals, Inc
P1/2
CC
(41)
PEXMETINIB
Melanoma
Dan Zandberg
P1/2
CC
(41)
prj1-3024
Melanoma
Zhuhai Yufan Biotechnologies Co., Ltd
P1/2
CC
(41)
Pumitamig
Melanoma
Bristol-Myers Squibb
P1/2
CC
(41)
RECOMBINANT FULLY HUMAN IGG1 KAPPA ANTI-TIGIT MONOCLONAL ANTIBODY EOS-448
Melanoma
iTeos Belgium SA
P1/2
CC
(41)
Regn10597
Melanoma
Regeneron Pharmaceuticals
P1/2
CC
(41)
Solnerstotug
Melanoma
Sensei Biotherapeutics, Inc.
P1/2
CC
(41)
Tarlatamab
Melanoma
University of Arizona
P1/2
CC
(41)
Tegavivint
Melanoma
Children's Oncology Group
P1/2
CC
(41)
TESTOSTERONE UNDECYLATE
Melanoma
Aminex Therapeutics, Inc.
P1/2
CC
(41)
Vodudeutentan sodium
Melanoma
ENB Therapeutics, Inc
P1/2
CC
(41)
XP-102
Melanoma
Xynomic Pharmaceuticals, Inc.
P1/2
CC
(41)
Zovostotug
Melanoma
OncoResponse, Inc.
P1/2
CC
(41)
Showing 176 to 200 of 308 assets
Previous
Page 8 of 13
Next